Archer Materials Advances Carbon-Based Quantum Computing and Biosensing Technologies by 2026
Archer Materials is developing carbon-based quantum technology and biosensors, focusing on manufacturability and scalability. The 12CQ project aims for a qubit demonstration in 2026, while the Biochip program targets potassium monitoring devices for medical diagnostics. Archer's strategy emphasizes integrating with existing semiconductor ecosystems to reduce costs and time to market, supported by collaborations with organizations like CSIRO and IMEC. The company maintains a debt-free balance sheet with $10.3 million in cash as of December 2025.
Theia Market Signal Identification - AI Assisted
Archer Materials is pursuing a scalable approach to quantum technology with its 12CQ project, targeting a carbon-based qubit demonstration in 2026. The company focuses on manufacturability and integration with existing semiconductor systems, aiming to lower capital requirements and accelerate time to market.
Additionally, Archer is developing a Biochip for monitoring blood potassium levels, with a prototype expected in 2026. Collaborations with CSIRO and IMEC support its efforts in quantum computing and biosensing. Archer remains debt-free with $10.3 million in cash, positioning itself for continued innovation in both quantum and medical diagnostics.
Comments